Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Įluting Coronary Stents. Of a Paclitaxel Releasing Balloon in Patients Presenting with In-stent Restenosis First-in-Man (PEPPER) trial.Ĭardiovascular Revascularization Medicine. International real-world DELUX registry EuroIntervention. Coronary artery treatment with paclitaxel-coated balloon using a BTHC excipient: clinical results of the The Pantera® Lux® DCB with its Lux® coating is part of the Lux® family of Paclitaxel-coated balloons from BIOTRONIK.ġ. Indicated for balloon dilatation for in-stent restenosis, de-novo lesions, acute or impending vascular occlusion and treatment of small vessel disease.* Pantera Lux has a 44% smaller crossing profile.ġ36% more force transmitted from hub to distal tip. Pantera Lux, with its lowest crossing profile, provides better pushability and Pig coronary artery Paclitaxel tissue concentrations Prolonged tissue retention at the target site 14, 15 The Lux coating technology blends paclitaxel with BTHC, a rapidly metabolized, safe and biocompatible excipient, thus improving bioavailability at the target site. Lux ®coating technology for rapid drug absorption
Investigating coronary drug-coated balloons for various implant-free Pantera Lux has proven efficacy and safety in multiple clinical trials Lux ® coating technology for rapid drug absorptionĬlinically proven solution for in-stent-restenosis and further indications 1-12 Clinically proven solution for in-stent-restenosis and further indications
0 kommentar(er)
